A 62-year-old male has a clinically N2b neck (multiple ipsilateral nodes, largest 3.5 cm, no extranodal extension on imaging). Following concurrent chemoradiotherapy, residual lymphadenopathy persists at 10 weeks. What is the appropriate next step?
- A Immediate salvage neck dissection
- B Repeat PET-CT at 6 months
- C Fine needle aspiration of the residual node
- D PET-CT at 12 weeks post-treatment completion ✓
Explanation
Current evidence-based guidelines recommend PET-CT at 12 weeks post-completion of chemoradiotherapy to assess neck response, as earlier imaging can have false-positive results due to inflammation and post-treatment changes. A negative PET-CT at 12 weeks has high negative predictive value (>95%) for neck disease, obviating the need for planned neck dissection. Salvage neck dissection is reserved for PET-confirmed persistent disease. FNAC alone is not reliable for post-treatment assessment.
Reference: Dhingra Diseases of Ear, Nose and Throat, 7th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.